Table 4.
Beliefs in Medicines Questionnaire scores at T1
| Group A: medication counseling had taken place | Group B: medication counseling had not taken place | Mann–Whitney U test | |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
| N | Median | IQR | N | Median | IQR | P values | |
| Specific necessities Range 5–25 |
164 | 24.0 | 20.0–25.0 | 60 | 23.0 | 21.0–25.0 | 0.28 |
| Specific concerns Range 5–25 |
166 | 13.0 | 10.0–18.0 | 62 | 15.0 | 9.0–17.0 | 0.15 |
| General overuse Range 4–20 |
161 | 12.0 | 11.0–16.0 | 63 | 13.0 | 8.0–14.0 | <0.01* |
| General harm Range 4–20 |
164 | 8.0 | 7.0–11.25 | 62 | 9.0 | 6.0–10.0 | 0.04* |
Note:
*
Shows statistical significance (P < 0.05).
Abbreviations: IQR, interquartile range; T1, second questionnaire administered to patients whose general practitioner had attended the training session and/or received a feedback report.